The aim of this study is to assess the prevalence of non-opioid drug use among opioid-addicted, buprenorphine injecting individuals in Georgia, during and after a 12-week course of buprenorphine–naloxone (Suboxone®) or methadone. (Source: Journal of Substance Abuse Treatment)